Evidence map›Paper›PMID 17881519›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2007

Nicotine-induced dystonic arousal complex in a mouse line harboring a human autosomal-dominant nocturnal frontal lobe epilepsy mutation.

Yaroslav Teper, Douglas Whyte, Elizabeth Cahir, Henry A Lester, Sharon R Grady, Michael J Marks, Bruce N Cohen, Carlos Fonck, Tristan McClure-Begley, J Michael McIntosh and 11 more

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 77 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Genetic epilepsy syndromes without structural brain abnormalities: clinical features and experimental models.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2014
    Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 7 institutions in 3 countries.

Yaroslav TeperHoward Florey Institute, The University of Melbourne, Victoria 3010, Australia.
Douglas Whyte
Elizabeth Cahir
Henry A Lester
Sharon R Grady
Michael J Marks
Bruce N Cohen
Carlos Fonck
Tristan McClure-Begley
J Michael McIntosh
Cesar Labarca
Andrew Lawrence
Feng Chen
Ilse Gantois
Philip J Davies
Steven Petrou
Mark Murphy
John Waddington
Malcolm K Horne
Samuel F Berkovic
John Drago
University of Melbourne · AUFlorey Institute of Neuroscience and Mental Health · AUCalifornia Institute of Technology · USUniversity of Colorado Boulder · USAustin Health · AURoyal College of Surgeons in Ireland · IEUniversity of Utah · US

Funding

GENETICS OF NICOTINE TOLERANCE: ROLE OF RECEPTORSR01DA003194 · NIDA · UNIVERSITY OF COLORADO AT BOULDER · PI MARKS, MICHAEL J · 1985 to 2013
$5.5M
Studies with Nicotinic Null Mutant MiceP30DA015663 · NIDA · UNIVERSITY OF COLORADO AT BOULDER · PI MARKS, MICHAEL J · 2003 to 2013
$4.5M
Novel Neuronal nAChR-Targeted PeptidesR01MH053631 · NIMH · UNIVERSITY OF UTAH · PI MCINTOSH, J MICHAEL · 2001 to 2011
$3.6M
ALPHA-CONOTOXIN MII--SELECTIVE NICOTINIC RECEPTOR PROBER01DA012242 · NIDA · UNIVERSITY OF COLORADO AT BOULDER · PI WHITEAKER, PAUL · 1999 to 2011
$3.5M
Central Nicotinic Receptors and Epileptic SeizuresR01NS043800 · NINDS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI COHEN, BRUCE N · 2001 to 2004
$993k
Autosomal dominant nocturnal frontal-lobe epilepsyR21NS046464 · NINDS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI LESTER, HENRY A. · 2003 to 2004
$385k
NOVEL NEURONAL NACHR-TARGETED PEPTIDESR29MH053631 · NIMH · UNIVERSITY OF UTAH · PI MCINTOSH, J MICHAEL · 1996 to 2000
$107k
NIDA NIH HHS P30 DA015663NIDA NIH HHS R01 DA003194NIDA NIH HHS R01 DA012242NIMH NIH HHS R01 MH053631NIMH NIH HHS R29 MH053631NINDS NIH HHS R01 NS043800NINDS NIH HHS R21 NS046464
6 · The paper itself

Abstract

We generated a mouse line harboring an autosomal-dominant nocturnal frontal lobe epilepsy (ADNFLE) mutation: the alpha4 nicotinic receptor S248F knock-in strain. In this mouse, modest nicotine doses (1-2 mg/kg) elicit a novel behavior termed the dystonic arousal complex (DAC). The DAC includes stereotypical head movements, body jerking, and forelimb dystonia; these behaviors resemble some core features of ADNFLE. A marked Straub tail is an additional component of the DAC. Similar to attacks in ADNFLE, the DAC can be partially suppressed by the sodium channel blocker carbamazepine or by pre-exposure to a very low dose of nicotine (0.1 mg/kg). The DAC is centrally mediated, genetically highly penetrant, and, surprisingly, not associated with overt ictal electrical activity as assessed by (1) epidural or frontal lobe depth-electrode electroencephalography or (2) hippocampal c-fos-regulated gene expression. Heterozygous knock-in mice are partially protected from nicotine-induced seizures. The noncompetitive antagonist mecamylamine does not suppress the DAC, although it suppresses high-dose nicotine-induced wild-type-like seizures. Experiments on agonist-induced 86Rb+ and neurotransmitter efflux from synaptosomes and on alpha4S248Fbeta2 receptors expressed in oocytes confirm that the S248F mutation confers resistance to mecamylamine blockade. Genetic background, gender, and mutant gene expression levels modulate expression of the DAC phenotype in mice. The S248F mouse thus appears to provide a model for the paroxysmal dystonic element of ADNFLE semiology. Our model complements what is seen in other ADNFLE animal models. Together, these mice cover the spectrum of behavioral and electrographic events seen in the human condition.

Indexed as

Disease Models, AnimalMutationAnimalsArousalDystonic DisordersEpilepsy, Frontal LobeFemaleHumansMaleMiceMice, Inbred C57BLMice, Neurologic MutantsMice, TransgenicNicotineRatsSpecies SpecificityNicotine

Identifiers

PMID17881519
PMCPMC6672658
OpenAlexW2052869591

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.